The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. We have developed a multi-dimensional remote patient eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and surgical follow-up period. We have developed the Breast Cancer Treatment Application (BCTA) that can facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures. Using a randomized controlled trial design, we will evaluate a variety of outcomes for breast cancer patients who will use the BCTA through their diagnosis and treatment. Our study will compare changes in patient activation over 1 year among newly diagnosed breast cancer patients between those using the BCTA and those receiving standard care. We will also evaluate anxiety, psychosocial well-being and quality of life between the two groups. To further understand the impact of the BCTA, we will assess the health services utilization and patient satisfaction outcomes. Our innovation will provide a solution to improve communication between patients and their healthcare providers